Abraham Nudelman

Ramat Gan, TA 52900, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Hybrid and Conjugate Drugs and their Antimicrobial, Antiparasitic, Antiamoebic, Antileishmanial, Antiprotozoal, and Antitrypanosomal Properties.

Hybrid and Conjugate Drugs and their Antimicrobial, Antiparasitic, Antiamoebic, Antileishmanial, Antiprotozoal, and Antitrypanosomal Properties.

Journal: Current medicinal chemistry

Published: August 26, 2025

Hybrids/Conjugates/Chimera Drugs-Antimicrobial Hybrids: Antibiotics, Antifungals, Antituberculars, Antimalarials.

Hybrids/Conjugates/Chimera Drugs-Antimicrobial Hybrids: Antibiotics, Antifungals, Antituberculars, Antimalarials.

Journal: Current medicinal chemistry

Published: October 21, 2024

Hybrid/Chimera Drugs - Part 1 - Drug Hybrids Affecting Diseases of the Central Nervous System.

Hybrid/Chimera Drugs - Part 1 - Drug Hybrids Affecting Diseases of the Central Nervous System.

Journal: Current medicinal chemistry

Published: January 25, 2024

Synthesis and preliminary biological evaluation of gabactyzine, a benactyzine-GABA mutual prodrug, as an organophosphate antidote.

Synthesis and preliminary biological evaluation of gabactyzine, a benactyzine-GABA mutual prodrug, as an organophosphate antidote.

Journal: Scientific reports

Published: July 11, 2022

Mutual Prodrugs - Codrugs.

Mutual Prodrugs - Codrugs.

Journal: Current medicinal chemistry

Published: May 31, 2022

An evaluation of the interaction of pixantrone with formaldehyde-releasing drugs in cancer cells.

An evaluation of the interaction of pixantrone with formaldehyde-releasing drugs in cancer cells.

Journal: Cancer chemotherapy and pharmacology

Published: December 06, 2021

Valproic Acid Prodrug Affects Selective Markers, Augments Doxorubicin Anticancer Activity and Attenuates Its Toxicity in a Murine Model of Aggressive Breast Cancer.

Valproic Acid Prodrug Affects Selective Markers, Augments Doxorubicin Anticancer Activity and Attenuates Its Toxicity in a Murine Model of Aggressive Breast Cancer.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 11, 2021

Comparison of the tissue distribution and metabolism of AN1284, a potent anti-inflammatory agent, after subcutaneous and oral administration in mice.

Comparison of the tissue distribution and metabolism of AN1284, a potent anti-inflammatory agent, after subcutaneous and oral administration in mice.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: April 21, 2021

Dimeric Drugs.

Dimeric Drugs.

Journal: Current medicinal chemistry

Published: April 18, 2021

A switch in mechanism of action prevents doxorubicin-mediated cardiac damage.

A switch in mechanism of action prevents doxorubicin-mediated cardiac damage.

Journal: Biochemical pharmacology

Published: October 22, 2020

Cardioprotection by AN-7, a prodrug of the histone deacetylase inhibitor butyric acid: Selective activity in hypoxic cardiomyocytes and cardiofibroblasts.

Cardioprotection by AN-7, a prodrug of the histone deacetylase inhibitor butyric acid: Selective activity in hypoxic cardiomyocytes and cardiofibroblasts.

Journal: European journal of pharmacology

Published: January 21, 2020

Conjugate prodrug AN-233 induces fetal hemoglobin expression in sickle erythroid progenitors and β-YAC transgenic mice.

Conjugate prodrug AN-233 induces fetal hemoglobin expression in sickle erythroid progenitors and β-YAC transgenic mice.

Journal: Blood cells, molecules & diseases

Published: July 08, 2019

Showing 1-12 of 29

Last Updated: 09/26/2026